Health ProductsNotice to Hospitals

Important Safety Information on Metallic Airway Stents – Notice to Hospitals

· Published by Health Canada · Official notice

Details

Alert type: Notice to Hospitals
Category: Medical Device
Issue: Medical Devices
Audience: Hospitals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

Notice about Health Canada advisories

 
[Text of letter begins]

Notice to Hospitals - Health Canada issued Important Safety Information on Metallic Airway Stents

September 8, 2005

To: Hospital Chief of Medical Staff

Please distribute to the relevant Departments of Surgery, Respirology, and other involved professional staff and post this NOTICE in your institution.

Subject: Complications associated with the use and removal of metallic airway stents in patients with benign airway obstruction

Metallic airway stents are being increasingly used in the treatment of patients with benign and malignant airway strictures. They offer many advantages over other stents such as ease of insertion, good conformation to irregular airways and a favourable internal-to-external diameter ratio. Health Canada is aware, however, of international reports of complications related to the use and removal of both covered and uncovered metallic airway stents including those outlined in a U.S. Food and Drug Administration Public Health Notice (July 29, 2005). Patients with benign airway obstruction are believed to be at higher risk because, on average, this group has a longer duration of stent therapy than those with malignant disease. Although no such incidents have been reported to the Health Products and Food Branch Inspectorate, Health Canada wishes to alert healthcare professionals to this information.

Reported complications during stent therapy include recurrent obstructions due to granulation tissue formation (requiring repeated interventions), stenosis at the ends of the stent, stent fracture, infection, stent migration and mucous obstruction. Additional complications associated with the removal of these stents include mucosal tears with bleeding, retention of pieces of metallic stent in the airway lining, the need for postoperative mechanical ventilation and perforation leading to tension pneumothorax. These stents can be removed intact but fracture or failure of the device during the procedure frequently forces a piecemeal removal. Also, further intervention (other types of stents, surgical correction) is required in many cases due to restenosis of the airway.

In order to minimize the risk of these and other complications associated with the use of metallic airway stents, Health Canada recommends the following:

  • review the labelling of these devices with particular attention paid to the indications for use, warnings and precautions
  • be selective in choosing patients to receive metallic airway stent therapy; carefully consider the expected length of time the device will be used and its need for future removal
  • in each case, compare and contrast the risk and benefits of metallic stents with other modalities used in the treatment of airway stenosis (surgical intervention, silicone stents); use metallic airway stents in patients with benign airway disease only after a thorough exploration of all other therapy options
  • if removal of a metallic airway stent is necessary, it should be performed by a physician trained in this procedure and in a setting prepared to deal with all of serious associated complications that may occur

Health Canada has completed a labelling review of the metallic tracheal stents licensed in Canada and will address labelling inadequacies in regulatory letters.

Health Canada depends on health care professionals to report adverse incidents related to medical devices. Any serious and/or unexpected adverse incident related to medical devices should be reported to Health Canada at the following address:

Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Tel: The Inspectorate Hotline 1-800-267-9675

For other inquiries: please refer to contact information:
Marketed Health Products Directorate (MHPD)
MHPD_DPSC@hc-sc.gc.ca
Tel/Tél : (613) 954-6522
Fax/Télé : (613) 952-7738

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.

[Text of letter ends]
 

References:

  • FDA Public Health Notification: Complications from Metallic Tracheal Stents in Patients with Benign Airway Disorders. July 29, 2005.
  • Lunn W, Feller-Kopman D, Wahidi M, Ashiku S, Thurer R, Ernst A. Endoscopic Removal of Metallic Airway Stents. Chest 2005; 127:2106-2112.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime